Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Shukhov OA"'
Autor:
Chelysheva EY; National Medical Research Center for Hematology., Petrova AN; National Medical Research Center for Hematology., Shukhov OA; National Medical Research Center for Hematology., Bykova AV; National Medical Research Center for Hematology., Nemchenko IS; National Medical Research Center for Hematology., Gurianova MA; National Medical Research Center for Hematology., Tsyba NN; National Medical Research Center for Hematology., Turkina AG; National Medical Research Center for Hematology.
Publikováno v:
Terapevticheskii arkhiv [Ter Arkh] 2022 Aug 12; Vol. 94 (7), pp. 836-843. Date of Electronic Publication: 2022 Aug 12.
Autor:
Petinati NA; National Medical Research Center for Hematology, Ministry of Health of the Russian Federation, Moscow, Russia. loel@mail.ru., Shipounova IN; National Medical Research Center for Hematology, Ministry of Health of the Russian Federation, Moscow, Russia., Fastova EA; National Medical Research Center for Hematology, Ministry of Health of the Russian Federation, Moscow, Russia., Magomedova AU; National Medical Research Center for Hematology, Ministry of Health of the Russian Federation, Moscow, Russia., Kravchenko SK; National Medical Research Center for Hematology, Ministry of Health of the Russian Federation, Moscow, Russia., Chelysheva EY; National Medical Research Center for Hematology, Ministry of Health of the Russian Federation, Moscow, Russia., Shukhov OA; National Medical Research Center for Hematology, Ministry of Health of the Russian Federation, Moscow, Russia., Turkina AG; National Medical Research Center for Hematology, Ministry of Health of the Russian Federation, Moscow, Russia., Sats NV; National Medical Research Center for Hematology, Ministry of Health of the Russian Federation, Moscow, Russia., Drize NI; National Medical Research Center for Hematology, Ministry of Health of the Russian Federation, Moscow, Russia., Parovichnikova EN; National Medical Research Center for Hematology, Ministry of Health of the Russian Federation, Moscow, Russia., Savchenko VG; National Medical Research Center for Hematology, Ministry of Health of the Russian Federation, Moscow, Russia.
Publikováno v:
Bulletin of experimental biology and medicine [Bull Exp Biol Med] 2021 Aug; Vol. 171 (4), pp. 553-558. Date of Electronic Publication: 2021 Sep 20.
Autor:
Gurianova MA; National Research Center for Hematology., Chelysheva EY; National Research Center for Hematology., Shukhov OA; National Research Center for Hematology., Turkina AG; National Research Center for Hematology.
Publikováno v:
Terapevticheskii arkhiv [Ter Arkh] 2020 Sep 01; Vol. 92 (7), pp. 90-94. Date of Electronic Publication: 2020 Sep 01.
Autor:
Petinati NA; National Medical Research Center for Hematology, Ministry of Health of the Russian Federation, Moscow, Russia., Petrova AN; National Medical Research Center for Hematology, Ministry of Health of the Russian Federation, Moscow, Russia., Chelysheva EY; National Medical Research Center for Hematology, Ministry of Health of the Russian Federation, Moscow, Russia., Shukhov OA; National Medical Research Center for Hematology, Ministry of Health of the Russian Federation, Moscow, Russia., Bykova AV; National Medical Research Center for Hematology, Ministry of Health of the Russian Federation, Moscow, Russia., Nemchenko IS; National Medical Research Center for Hematology, Ministry of Health of the Russian Federation, Moscow, Russia., Sats NV; National Medical Research Center for Hematology, Ministry of Health of the Russian Federation, Moscow, Russia., Turkina AG, Drize NI; National Medical Research Center for Hematology, Ministry of Health of the Russian Federation, Moscow, Russia. loel@mail.ru.
Publikováno v:
Bulletin of experimental biology and medicine [Bull Exp Biol Med] 2019 Aug; Vol. 167 (4), pp. 580-583. Date of Electronic Publication: 2019 Sep 09.
Autor:
Lavrov AV; Laboratory of Mutagenesis, Federal State Budgetary Institution, Research Centre for Medical Genetics, Moskvorechie str., 1, Moscow, Russian Federation, 115522. alexandervlavrov@gmail.com.; Department of Molecular and Cellular Genetics, State Budgetary Educational Institution of Higher Professional Education 'Russian National Research Medical University named after N.I. Pirogov' of Ministry of Health of the Russian Federation, Ostrovityanova str., 1, Moscow, Russian Federation, 117997. alexandervlavrov@gmail.com., Chelysheva EY; Scientific and Advisory Department of Chemotherapy of Myeloproliferative disorders, Federal State-Funded Institution National Research Center for Hematology of the Ministry of Healthcare of the Russian Federation, Novy Zykovki proezd, 4, Moscow, Russian Federation, 125167., Adilgereeva EP; Laboratory of Mutagenesis, Federal State Budgetary Institution, Research Centre for Medical Genetics, Moskvorechie str., 1, Moscow, Russian Federation, 115522., Shukhov OA; Scientific and Advisory Department of Chemotherapy of Myeloproliferative disorders, Federal State-Funded Institution National Research Center for Hematology of the Ministry of Healthcare of the Russian Federation, Novy Zykovki proezd, 4, Moscow, Russian Federation, 125167., Smirnikhina SA; Laboratory of Mutagenesis, Federal State Budgetary Institution, Research Centre for Medical Genetics, Moskvorechie str., 1, Moscow, Russian Federation, 115522., Kochergin-Nikitsky KS; Laboratory of Mutagenesis, Federal State Budgetary Institution, Research Centre for Medical Genetics, Moskvorechie str., 1, Moscow, Russian Federation, 115522., Yakushina VD; Laboratory of Mutagenesis, Federal State Budgetary Institution, Research Centre for Medical Genetics, Moskvorechie str., 1, Moscow, Russian Federation, 115522., Tsaur GA; Regional Children Hospital 1, S. Deryabinoy str., 32, Ekaterinburg, Russian Federation, 620149.; Research Institute of Medical Cell Technologies, Soboleva str., 25, Ekaterinburg, Russian Federation, 620905.; Federal State Budgetary Educational Institution of Higher Education, Urals State Medical University of the Ministry of Healthcare of the Russian Federation, Repina str., 3, Ekaterinburg, Russian Federation, 620028., Mordanov SV; Laboratory of Medical Genetics, The Rostov State Medical University, Nahichevansky av., 29, Rostov-on-Don, Russian Federation, 344022., Turkina AG; Scientific and Advisory Department of Chemotherapy of Myeloproliferative disorders, Federal State-Funded Institution National Research Center for Hematology of the Ministry of Healthcare of the Russian Federation, Novy Zykovki proezd, 4, Moscow, Russian Federation, 125167., Kutsev SI; Laboratory of Mutagenesis, Federal State Budgetary Institution, Research Centre for Medical Genetics, Moskvorechie str., 1, Moscow, Russian Federation, 115522.; Department of Molecular and Cellular Genetics, State Budgetary Educational Institution of Higher Professional Education 'Russian National Research Medical University named after N.I. Pirogov' of Ministry of Health of the Russian Federation, Ostrovityanova str., 1, Moscow, Russian Federation, 117997.
Publikováno v:
BMC medical genomics [BMC Med Genomics] 2019 Mar 13; Vol. 12 (Suppl 2), pp. 37. Date of Electronic Publication: 2019 Mar 13.
Autor:
Smirnikhina SA; a Laboratory of Mutagenesis , FSBI 'Research Centre for Medical Genetics' , Moscow , Russian Federation., Chelysheva EY; b Scientific and Advisory Department of Chemotherapy of Myeloproliferative disorders , FSFI 'National Research Center for Hematology' of the Ministry of Healthcare of the Russian Federation , Moscow , Russian Federation., Lavrov AV; a Laboratory of Mutagenesis , FSBI 'Research Centre for Medical Genetics' , Moscow , Russian Federation.; c Department of Molecular and Cellular Genetics , The Russian National Research Medical University Named after N.I. Pirogov , Moscow , Russian Federation., Kochergin-Nikitsky KS; a Laboratory of Mutagenesis , FSBI 'Research Centre for Medical Genetics' , Moscow , Russian Federation., Mozgovoy IV; c Department of Molecular and Cellular Genetics , The Russian National Research Medical University Named after N.I. Pirogov , Moscow , Russian Federation., Adilgereeva EP; a Laboratory of Mutagenesis , FSBI 'Research Centre for Medical Genetics' , Moscow , Russian Federation., Shukhov OA; b Scientific and Advisory Department of Chemotherapy of Myeloproliferative disorders , FSFI 'National Research Center for Hematology' of the Ministry of Healthcare of the Russian Federation , Moscow , Russian Federation., Petrova AN; b Scientific and Advisory Department of Chemotherapy of Myeloproliferative disorders , FSFI 'National Research Center for Hematology' of the Ministry of Healthcare of the Russian Federation , Moscow , Russian Federation., Bykova AV; b Scientific and Advisory Department of Chemotherapy of Myeloproliferative disorders , FSFI 'National Research Center for Hematology' of the Ministry of Healthcare of the Russian Federation , Moscow , Russian Federation., Abdullaev AO; b Scientific and Advisory Department of Chemotherapy of Myeloproliferative disorders , FSFI 'National Research Center for Hematology' of the Ministry of Healthcare of the Russian Federation , Moscow , Russian Federation., Turkina AG; b Scientific and Advisory Department of Chemotherapy of Myeloproliferative disorders , FSFI 'National Research Center for Hematology' of the Ministry of Healthcare of the Russian Federation , Moscow , Russian Federation., Kutsev SI; a Laboratory of Mutagenesis , FSBI 'Research Centre for Medical Genetics' , Moscow , Russian Federation.; c Department of Molecular and Cellular Genetics , The Russian National Research Medical University Named after N.I. Pirogov , Moscow , Russian Federation.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2018 Oct; Vol. 59 (10), pp. 2512-2515. Date of Electronic Publication: 2018 Feb 09.
Autor:
Lavrov AV; Laboratory of Mutagenesis, Federal State Budgetary Institution Research Centre for Medical Genetics, Moscow, Russian Federation.; Department of Molecular and Cellular Genetics, State Budgetary Educational Institution of Higher Professional Education Russian National Research Medical University named after N.I. Pirogov of Ministry of Health of the Russian Federation, Moscow, Russian Federation., Ustaeva OA; Laboratory of Medical Genetics, The Rostov State Medical University, Rostov-on-Don, Russian Federation., Adilgereeva EP; Laboratory of Mutagenesis, Federal State Budgetary Institution Research Centre for Medical Genetics, Moscow, Russian Federation., Smirnikhina SA; Laboratory of Mutagenesis, Federal State Budgetary Institution Research Centre for Medical Genetics, Moscow, Russian Federation., Chelysheva EY; Scientific and Advisory Department of Chemotherapy of Myeloproliferative disorders, Federal State-Funded Institution National Research Center for Hematology of the Ministry of Healthcare of the Russian Federation, Moscow, Russian Federation., Shukhov OA; Scientific and Advisory Department of Chemotherapy of Myeloproliferative disorders, Federal State-Funded Institution National Research Center for Hematology of the Ministry of Healthcare of the Russian Federation, Moscow, Russian Federation., Shatokhin YV; Laboratory of Medical Genetics, The Rostov State Medical University, Rostov-on-Don, Russian Federation., Mordanov SV; Laboratory of Medical Genetics, The Rostov State Medical University, Rostov-on-Don, Russian Federation., Turkina AG; Scientific and Advisory Department of Chemotherapy of Myeloproliferative disorders, Federal State-Funded Institution National Research Center for Hematology of the Ministry of Healthcare of the Russian Federation, Moscow, Russian Federation., Kutsev SI; Laboratory of Mutagenesis, Federal State Budgetary Institution Research Centre for Medical Genetics, Moscow, Russian Federation.; Department of Molecular and Cellular Genetics, State Budgetary Educational Institution of Higher Professional Education Russian National Research Medical University named after N.I. Pirogov of Ministry of Health of the Russian Federation, Moscow, Russian Federation.
Publikováno v:
PloS one [PLoS One] 2017 Sep 13; Vol. 12 (9), pp. e0182901. Date of Electronic Publication: 2017 Sep 13 (Print Publication: 2017).
Autor:
Turkina AG; National Medical Research Center for Hematology, Ministry of Health of Russia, Moscow, Russia., Chelysheva EY; National Medical Research Center for Hematology, Ministry of Health of Russia, Moscow, Russia., Shuvaev VA; Russian Research Institute of Hematology and Transfusiology, Federal Biomedical Agency of Russia, Saint Petersburg, Russia., Gusarova GA; National Medical Research Center for Hematology, Ministry of Health of Russia, Moscow, Russia., Bykova AV; National Medical Research Center for Hematology, Ministry of Health of Russia, Moscow, Russia., Shukhov OA; National Medical Research Center for Hematology, Ministry of Health of Russia, Moscow, Russia., Petrova AN; National Medical Research Center for Hematology, Ministry of Health of Russia, Moscow, Russia., Vakhrusheva MV; National Medical Research Center for Hematology, Ministry of Health of Russia, Moscow, Russia., Goryacheva SR; National Medical Research Center for Hematology, Ministry of Health of Russia, Moscow, Russia., Kolosova LY; National Medical Research Center for Hematology, Ministry of Health of Russia, Moscow, Russia., Krasikova PS; Orenburg Regional Clinical Hospital, Orenburg, Russia., Fominykh MS; Russian Research Institute of Hematology and Transfusiology, Federal Biomedical Agency of Russia, Saint Petersburg, Russia., Martynkevich IS; Russian Research Institute of Hematology and Transfusiology, Federal Biomedical Agency of Russia, Saint Petersburg, Russia., Abdullaev AO; National Medical Research Center for Hematology, Ministry of Health of Russia, Moscow, Russia., Sudarikov AB; National Medical Research Center for Hematology, Ministry of Health of Russia, Moscow, Russia., Savchenko VG; National Medical Research Center for Hematology, Ministry of Health of Russia, Moscow, Russia.
Publikováno v:
Terapevticheskii arkhiv [Ter Arkh] 2017; Vol. 89 (12), pp. 86-96.
Autor:
Smirnikhina SA; a Federal State Budgetary Institution 'Research Centre for Medical Genetics' , Moscow , Russian Federation ;, Lavrov AV; a Federal State Budgetary Institution 'Research Centre for Medical Genetics' , Moscow , Russian Federation ;; b The Russian National Research Medical University Named after N.I. Pirogov , Moscow , Russian Federation ;, Chelysheva EY; c Scientific and Advisory Department of Chemotherapy of Myeloproliferative Disorders , Federal State-Funded Institution 'National Research Center for Hematology' of the Ministry of Healthcare of the Russian Federation , Moscow , Russian Federation., Adilgereeva EP; a Federal State Budgetary Institution 'Research Centre for Medical Genetics' , Moscow , Russian Federation ;, Shukhov OA; c Scientific and Advisory Department of Chemotherapy of Myeloproliferative Disorders , Federal State-Funded Institution 'National Research Center for Hematology' of the Ministry of Healthcare of the Russian Federation , Moscow , Russian Federation., Turkina A; c Scientific and Advisory Department of Chemotherapy of Myeloproliferative Disorders , Federal State-Funded Institution 'National Research Center for Hematology' of the Ministry of Healthcare of the Russian Federation , Moscow , Russian Federation., Kutsev SI; a Federal State Budgetary Institution 'Research Centre for Medical Genetics' , Moscow , Russian Federation ;; b The Russian National Research Medical University Named after N.I. Pirogov , Moscow , Russian Federation ;
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2016 Jul; Vol. 57 (7), pp. 1669-76. Date of Electronic Publication: 2016 Jan 12.
Autor:
Lavrov AV; Laboratory of Mutagenesis, Federal State Budgetary Institution 'Research Centre for Medical Genetics', Moskvorechie, 1, Moscow, 115478, Russia. alexandervlavrov@gmail.com.; Department of Molecular and Cellular Genetics, State Budgetary Educational Institution of Higher Professional Education 'Russian National Research Medical University named after N.I. Pirogov' of Ministry of Health of the Russian Federation, Moscow, Russia. alexandervlavrov@gmail.com., Chelysheva EY; Scientific and Advisory Department of Chemotherapy of Myeloproliferative Disorders, Federal State-Funded Institution National Research Center for Hematology of the Ministry of Healthcare of the Russian Federation, Moscow, Russia., Smirnikhina SA; Laboratory of Mutagenesis, Federal State Budgetary Institution 'Research Centre for Medical Genetics', Moskvorechie, 1, Moscow, 115478, Russia., Shukhov OA; Scientific and Advisory Department of Chemotherapy of Myeloproliferative Disorders, Federal State-Funded Institution National Research Center for Hematology of the Ministry of Healthcare of the Russian Federation, Moscow, Russia., Turkina AG; Scientific and Advisory Department of Chemotherapy of Myeloproliferative Disorders, Federal State-Funded Institution National Research Center for Hematology of the Ministry of Healthcare of the Russian Federation, Moscow, Russia., Adilgereeva EP; Laboratory of Mutagenesis, Federal State Budgetary Institution 'Research Centre for Medical Genetics', Moskvorechie, 1, Moscow, 115478, Russia., Kutsev SI; Laboratory of Mutagenesis, Federal State Budgetary Institution 'Research Centre for Medical Genetics', Moskvorechie, 1, Moscow, 115478, Russia.; Department of Molecular and Cellular Genetics, State Budgetary Educational Institution of Higher Professional Education 'Russian National Research Medical University named after N.I. Pirogov' of Ministry of Health of the Russian Federation, Moscow, Russia.
Publikováno v:
BMC genetics [BMC Genet] 2016 Jan 27; Vol. 17 Suppl 1, pp. 14. Date of Electronic Publication: 2016 Jan 27.